IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $331,672 | +12.7% | 7,312 | +2.0% | 0.03% | +14.8% |
| Q2 2023 | $294,226 | -38.3% | 7,171 | -43.2% | 0.03% | -70.3% |
| Q4 2022 | $476,808 | +5.3% | 12,624 | +23.2% | 0.09% | -3.2% |
| Q3 2022 | $453,000 | 0.0% | 10,248 | -16.2% | 0.09% | -45.7% |
| Q2 2022 | $453,000 | +62.9% | 12,225 | +62.6% | 0.17% | +66.3% |
| Q1 2022 | $278,000 | -22.8% | 7,518 | -36.5% | 0.10% | +8.3% |
| Q4 2021 | $360,000 | +6.2% | 11,845 | +106.0% | 0.10% | +28.0% |
| Q2 2020 | $339,000 | 0.0% | 5,749 | -19.8% | 0.08% | -93.1% |
| Q1 2020 | $339,000 | – | 7,168 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |